Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Level-adapted vs Weight-based Ribavirin in Treatment-naive Chronic Hepatitis C Genotype 1
NCT00944684Phase 2Completed
- Sponsor
- University of Bern
- Start
- Nov 2007
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ribavirin in hepatitis C (HCV) (2 arms), sponsored by University of Bern. Primary endpoint: Sustained virological response at 1 Day. Started Nov 2007; status: completed.
02
Drugs
ribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00944684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944684.